Piotr Łacina

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Ankylosing Spondylitis

Multiple Myeloma

Top Venues

Disease markers

Journal of clinical medicine

Molecular carcinogenesis

International journal of immunogenetics

This page only lists publications with an associated author ORCID identifier.

Publications

Piotr Łacina, Aleksandra Butrym, Eliza Turlej, Martyna Stachowicz-Suhs, Joanna Wietrzyk, Grzegorz Mazur, Katarzyna Bogunia-Kubik
BSG (CD147) Serum Level and Genetic Variants Are Associated with Overall Survival in Acute Myeloid Leukaemia. Journal of clinical medicine 11 (2) (2022)
Piotr Łacina, Aleksandra Butrym, Diana Frontkiewicz, Grzegorz Mazur, Katarzyna Bogunia-Kubik
Soluble CD147 (BSG) as a Prognostic Marker in Multiple Myeloma. Current issues in molecular biology 44 (1) (2022)
Katarzyna Wicherska-Pawłowska, Katarzyna Bogunia-Kubik, Bartłomiej Kuszczak, Piotr Łacina, Marta Dratwa, Bożena Jaźwiec, Tomasz Wróbel, Justyna Rybka
Polymorphisms in the Genes Coding for TLRs, NLRs and RLRs Are Associated with Clinical Parameters of Patients with Acute Myeloid Leukemia. International journal of molecular sciences 23 (17) (2022)
Joanna Wielinska, Rachel E Crossland, Piotr Łacina, Jerzy Świerkot, Bartosz Bugaj, Anne M Dickinson, Katarzyna Bogunia-Kubik
Exploring the Extracellular Vesicle MicroRNA Expression Repertoire in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with TNF Inhibitors. Disease markers 2021 (2021)
Piotr Łacina, Aleksandra Butrym, Michał Humiński, Marta Dratwa, Diana Frontkiewicz, Grzegorz Mazur, Katarzyna Bogunia-Kubik
Association of RANK and RANKL gene polymorphism with survival and calcium levels in multiple myeloma. Molecular carcinogenesis 60 (2) (2020)
Katarzyna Bogunia-Kubik, Piotr Łacina
Non-KIR NK cell receptors: Role in transplantation of allogeneic haematopoietic stem cells. International journal of immunogenetics 48 (2) (2020)